Allogeneic hematopoietic stem cell transplantation (HSCT) for high-risk acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS): How can we improve outcomes in the near future?

被引：10
作者：
Phillips, Gordon L. [1 ]
机构：
[1] Univ Rochester, Med Ctr, Blood & Marrow Transplant Program, JP Wilmot Canc Ctr,Strong Mem Hosp, Rochester, NY 14642 USA
来源：
LEUKEMIA RESEARCH | 2012年 / 36卷 / 12期
关键词：
Allogeneic; Transplantation; Acute myeloid leukemia; Myelodysplastic; Improve outcomes; ACUTE MYELOGENOUS LEUKEMIA; 1ST COMPLETE REMISSION; TOTAL-BODY IRRADIATION; HEMATOLOGIC MALIGNANCIES; RELAPSE; BUSULFAN; FLUDARABINE; REGIMENS; CHEMOTHERAPY; MORTALITY;
D O I：
10.1016/j.leukres.2012.08.004
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1490 / 1495
页数：6
相关论文
共 36 条
  • [1] Myeloablative Reduced-Toxicity i.v. Busulfan-Fludarabine and Allogeneic Hematopoietic Stem Cell Transplant for Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome in the Sixth through Eighth Decades of Life
    Alatrash, Gheath
    de Lima, Marcos
    Hamerschlak, Nelson
    Pelosini, Matteo
    Wang, Xuemei
    Xiao, Lianchun
    Kerbauy, Fabio
    Chiattone, Alexandre
    Rondon, Gabriela
    Qazilbash, Muzaffar H.
    Giralt, Sergio A.
    Silva, Leandro de Padua
    Hosing, Chitra
    Kebriaei, Partow
    Zhang, Weiqing
    Nieto, Yago
    Saliba, Rima M.
    Champlin, Richard E.
    Andersson, Borje S.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (10) : 1490 - 1496
  • [2] Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS
    Andersson, Borje S.
    de Lima, Marcos
    Thall, Peter F.
    Wang, Xuemei
    Couriel, Daniel
    Korbling, Martin
    Roberson, Soonja
    Giralt, Sergio
    Pierre, Betty
    Russell, James A.
    Shpall, Elizabeth J.
    Jones, Roy B.
    Champlin, Richard E.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (06) : 672 - 684
  • [3] Optimising the conditioning regimen for acute myeloid leukaemia
    Appelbaum, Frederick R.
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2009, 22 (04) : 543 - 550
  • [4] Monitoring and Prevention of Relapse after Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignancies
    Bacher, Ulrike
    Talano, Julie-An
    Bishop, Michael R.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (01) : S62 - S73
  • [5] Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant
    Ballen, Karen K.
    Koreth, John
    Chen, Yi-Bin
    Dey, Bimalangshu R.
    Spitzer, Thomas R.
    [J]. BLOOD, 2012, 119 (09) : 1972 - 1980
  • [6] Prognostic index for adult patients with acute myeloid leukemia in first relapse
    Breems, DA
    Van Putten, WLJ
    Huijgens, PC
    Ossenkoppele, GJ
    Verhoef, GEG
    Verdonck, LF
    Vellenga, E
    De Greef, G
    Jacky, E
    Van der Lelie, J
    Boogaerts, MA
    Löwenberg, B
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (09) : 1969 - 1978
  • [7] Busulfan in Hematopoietic Stem Cell Transplantation
    Ciurea, Stefan O.
    Andersson, Borje S.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (05) : 523 - 536
  • [8] Long-term follow-up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia
    Clift, RA
    Buckner, CD
    Appelbaum, FR
    Sullivan, KM
    Storb, R
    Thomas, ED
    [J]. BLOOD, 1998, 92 (04) : 1455 - 1456
  • [9] Comparative Analysis of the Value of Allogeneic Hematopoietic Stem-Cell Transplantation in Acute Myeloid Leukemia With Monosomal Karyotype Versus Other Cytogenetic Risk Categories
    Cornelissen, Jan J.
    Breems, Dimitri
    van Putten, Wim L. J.
    Gratwohl, Alois A.
    Passweg, Jakob R.
    Pabst, Thomas
    Maertens, Johan
    Beverloo, H. Berna
    Kooy, Marinus van Marwijk
    Wijermans, Pierre W.
    Biemond, Bart J.
    Vellenga, Edo
    Verdonck, Leo F.
    Ossenkoppele, Gert J.
    Lowenberg, Bob
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (17) : 2140 - 2146
  • [10] Transplantation Conditioning Regimens: Can We Say It Better?
    Deeg, H. Joachim
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (06) : 653 - 655
1234